GEFYRA Trademark
GEFYRA is a USPTO trademark filed by SANOFI. Status: Registered.
Prosecution Summary
**Trademark Summary** **GEFYRA** is a standard character mark owned by **Sanofi**, a French corporation, covering chemical preparations and biological compounds for pharmaceutical manufacturing in Class 001, pharmaceutical preparations including antibodies for treating rare diseases and oncologic, immunologic, and neurologic disorders in Class 005, and scientific research services in biotechnology and pharmaceuticals in Class 042. The mark is **registered** on the Principal Register since November 28, 2023, with registration number 7226908. No notable issues or legal proceedings are present. **Recent Activity** Filed May 5, 2022, as a Madrid Protocol extension from international registration WO1666858 with priority date April 21, 2022, the application faced a non-final office action i
Trademark Facts
| Mark | GEFYRA |
|---|---|
| Serial Number | 79342700 |
| Registration Number | 7226908 |
| Status | Registered |
| Filing Date | 2022-05-05 |
| Registration Date | 2023-11-28 |
| Mark Type | Word |
| Nice Classes | 042 (Software & IT) |
| Owner | SANOFI |
| Attorney of Record | Karen Lim |
| Prosecution Events | 29 |
| Latest Event | FINO on 2024-03-26 |
Goods & Services
Chemical preparations used in the manufacture of pharmaceutical products; biological compounds being biological preparations used in the manufacture of pharmaceutical products, namely, antibodies | Pharmaceutical preparations for the treatment of rare diseases, rare blood disorders, and oncologic, immunologic, and neurologic diseases and disorders; monoclonal and polyclonal antibodies for medical purposes; diagnostic preparations for medical and veterinary use; biological tissue cultures for medical and veterinary use | Scientific research and laboratory research services in the field of biotechnology; biotechnical research; advice being consulting services in the field of biotechnology, bacteriological research, biological research, research and development of new pharmaceutical products and new component products for third parties, medical and scientific research, namely, conducting clinical trials for others, chemical analysis and research services, medical research, pharmaceutical research services